83 research outputs found

    Heterogeneous Ensemble Learning for Enhanced Crash Forecasts -- A Frequentest and Machine Learning based Stacking Framework

    Full text link
    A variety of statistical and machine learning methods are used to model crash frequency on specific roadways with machine learning methods generally having a higher prediction accuracy. Recently, heterogeneous ensemble methods (HEM), including stacking, have emerged as more accurate and robust intelligent techniques and are often used to solve pattern recognition problems by providing more reliable and accurate predictions. In this study, we apply one of the key HEM methods, Stacking, to model crash frequency on five lane undivided segments (5T) of urban and suburban arterials. The prediction performance of Stacking is compared with parametric statistical models (Poisson and negative binomial) and three state of the art machine learning techniques (Decision tree, random forest, and gradient boosting), each of which is termed as the base learner. By employing an optimal weight scheme to combine individual base learners through stacking, the problem of biased predictions in individual base-learners due to differences in specifications and prediction accuracies is avoided. Data including crash, traffic, and roadway inventory were collected and integrated from 2013 to 2017. The data are split into training, validation, and testing datasets. Estimation results of statistical models reveal that besides other factors, crashes increase with density (number per mile) of different types of driveways. Comparison of out-of-sample predictions of various models confirms the superiority of Stacking over the alternative methods considered. From a practical standpoint, stacking can enhance prediction accuracy (compared to using only one base learner with a particular specification). When applied systemically, stacking can help identify more appropriate countermeasures.Comment: This paper was presented at the 101st Transportation Research Board Annual Meeting (TRBAM) by National Academy of Sciences in January 2022 in Washington D.C. The paper is currently under review for potential publication in an Impact Factor Journa

    What is the Effect of Commute Time on Employment? An Analysis of Spatial Patterns in the New York Metropolitan Area

    Get PDF
    This study uses 1995 Nationwide Personal Transportation Survey (NPTS) data to determine the effect of commute time, a measure of accessibility, on employment for residents of the New York- Northern New Jersey-Long Island consolidated metropolitan statistical area (CMSA). The study uses two models to test the hypothesis that higher commute times are associated with lower employment probabilities, and considers both employed and non-employed individuals and private vehicle and public transit commute modes. In the first model, an ordinary least squares regression is used to predict commute time by auto and transit for all New York CMSA respondents (regardless of whether employed) on the basis of individual, household, neighborhood, and workplace characteristics. In the second model, a binary probit model estimates employment probability on the basis of individual, household, and neighborhood characteristics, as well as predicted commute time. The policy implications of the findings are discussed

    Exploring multiple eco-routing guidance strategies in a commuting corridor

    Get PDF
    The introduction of eco-routing systems has been suggested as a promising strategy to reduce carbon dioxide emissions and criteria pollutants. The objective of this study is to scrutinize the impacts of an eco-routing guidance system on emissions through the use of a case study in a commuting corridor. This research aims at assessing the potential environmental benefits in terms of different pollutant emissions. Simultaneously, it addresses the extent of variations in system travel time that each eco-routing strategy implies. The methodology consists of three distinct phases. The first phase corresponded to the adjustment of a micro simulation platform of traffic and emissions with empirical data previously collected. Secondly, volume-emission-functions (VEF) were developed based on the integrated modelling structure. Finally, different scenarios of traffic flow optimization were performed at the network level based on a simplified assignment procedure. The results show that if the traffic assignment is performed with the objective of minimize overall impacts, total system environmental damage costs can be reduced up to 9% with marginal oscillations in total system travel time. However, if drivers are advised based on their own emissions minimization, total system emissions may be higher than under the standard user equilibrium flow pattern. Specifically, environmentally friendly navigation algorithms focused on individual goals may tend to do divert traffic to roads with less capacity affecting the performance of the remaining traffic. This case study brings new insights about the difficulties and potentials of implementing such systems

    Basic science232. Certolizumab pegol prevents pro-inflammatory alterations in endothelial cell function

    Get PDF
    Background: Cardiovascular disease is a major comorbidity of rheumatoid arthritis (RA) and a leading cause of death. Chronic systemic inflammation involving tumour necrosis factor alpha (TNF) could contribute to endothelial activation and atherogenesis. A number of anti-TNF therapies are in current use for the treatment of RA, including certolizumab pegol (CZP), (Cimzia ®; UCB, Belgium). Anti-TNF therapy has been associated with reduced clinical cardiovascular disease risk and ameliorated vascular function in RA patients. However, the specific effects of TNF inhibitors on endothelial cell function are largely unknown. Our aim was to investigate the mechanisms underpinning CZP effects on TNF-activated human endothelial cells. Methods: Human aortic endothelial cells (HAoECs) were cultured in vitro and exposed to a) TNF alone, b) TNF plus CZP, or c) neither agent. Microarray analysis was used to examine the transcriptional profile of cells treated for 6 hrs and quantitative polymerase chain reaction (qPCR) analysed gene expression at 1, 3, 6 and 24 hrs. NF-κB localization and IκB degradation were investigated using immunocytochemistry, high content analysis and western blotting. Flow cytometry was conducted to detect microparticle release from HAoECs. Results: Transcriptional profiling revealed that while TNF alone had strong effects on endothelial gene expression, TNF and CZP in combination produced a global gene expression pattern similar to untreated control. The two most highly up-regulated genes in response to TNF treatment were adhesion molecules E-selectin and VCAM-1 (q 0.2 compared to control; p > 0.05 compared to TNF alone). The NF-κB pathway was confirmed as a downstream target of TNF-induced HAoEC activation, via nuclear translocation of NF-κB and degradation of IκB, effects which were abolished by treatment with CZP. In addition, flow cytometry detected an increased production of endothelial microparticles in TNF-activated HAoECs, which was prevented by treatment with CZP. Conclusions: We have found at a cellular level that a clinically available TNF inhibitor, CZP reduces the expression of adhesion molecule expression, and prevents TNF-induced activation of the NF-κB pathway. Furthermore, CZP prevents the production of microparticles by activated endothelial cells. This could be central to the prevention of inflammatory environments underlying these conditions and measurement of microparticles has potential as a novel prognostic marker for future cardiovascular events in this patient group. Disclosure statement: Y.A. received a research grant from UCB. I.B. received a research grant from UCB. S.H. received a research grant from UCB. All other authors have declared no conflicts of interes

    Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

    Get PDF
    Summary Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung’s disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung’s disease) from 264 hospitals (89 in high-income countries, 166 in middleincome countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in lowincome countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between lowincome, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030
    • …
    corecore